📅 PUBMED DAILY TRIAGE — 2026-10-28 Window: 2026-10-27T09:00:00Z → 2026-10-28T09:00:00Z (CRDT) Topics scanned: 10 | Articles reviewed: 130 | Candidates evaluated: 135 High priority: 7 | Standard: 38 | Low/archive: 0 | Unsolicited finds: 9 Run status: SUCCESS
🔴🟠 HIGH PRIORITY — Best Finds by Topic
Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma)
Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma): No high-priority finds today (best candidate scored 5/10).
CBC-based diagnostics and machine learning in hematology
CBC-based diagnostics and machine learning in hematology: No high-priority finds today (best candidate scored 5/10).
Early cancer detection (liquid biopsy, ctDNA, cfDNA)
PMID 42938921 · FragMIL: A Fragment-Token Multiple-Instance Learning Framework for Cancer Detection from Cell-Free DNA Fragmentomics. · 5/10 · Journal article; PubMed abstract reviewed; conservative score reflects design, direct relevance, and evidence maturity.
AI/ML in clinical diagnostics and imaging
AI/ML in clinical diagnostics and imaging: No high-priority finds today (best candidate scored 7/10).
Precision oncology and genomic medicine
Precision oncology and genomic medicine: No high-priority finds today (best candidate scored 5/10).
Novel therapeutics: immunotherapy, CAR-T, targeted therapy
Novel therapeutics: immunotherapy, CAR-T, targeted therapy: No high-priority finds today (best candidate scored 5/10).
Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk
PMID 42946897 · Cardiovascular Effects of GLP-1 Receptor Agonists Across Age Groups: An Updated Meta-Analysis of Randomized Controlled Trials. · 8/10 · Systematic review and meta-analysis; PubMed abstract reviewed; synthesis was scored conservatively and no evidence-dependent priority flag was applied.
Aging, longevity, and population health
Aging, longevity, and population health: No high-priority finds today (best candidate scored 6/10).
Rare diseases with high unmet need
PMID 42944976 · Three-Year Follow-Up of Delandistrogene Moxeparvovec in Duchenne Muscular Dystrophy: Long-Term Phase 3 EMBARK Trial Results. · 10/10 · Phase III clinical trial; PubMed abstract reviewed; conservative score reflects design, direct relevance, and evidence maturity.
🟢⚪ STANDARD (4–7) — Top by Topic
Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma)
PMID 42946406 · Association Between Proton Pump Inhibitor Use and Febrile Neutropenia During R-CHOP Therapy in Patients With Non-Hodgkin Lymphoma. · 5/10 · Other PMID 42946491 · Pan-uveitis as the first presentation of classical Hodgkin lymphoma. · 5/10 · Other PMID 42946894 · ALK-positive large B-cell lymphoma with plasmacytoid predominance and a novel CEP128::ALK fusion. · 5/10 · Other PMID 42947249 · Diffuse large B cell lymphoma in rheumatoid arthritis express polyreactive and autoreactive BCRs binding protein modifications. · 5/10 · Other PMID 42947288 · Baseline Monoclonal Protein Identifies Plasmacytic Differentiation and Shorter Progression-Free Survival in Marginal Zone Lymphoma. · 5/10 · Other
CBC-based diagnostics and machine learning in hematology
PMID 42938973 · Machine Learning-Based Multiclass Classification of Hb E Carrier Status and Thalassemia-Related Hematological Profiles Using Routine Complete Blood Count Parameters. · 5/10 · Diagnostics
Early cancer detection (liquid biopsy, ctDNA, cfDNA)
PMID 42946309 · Prospective circulating tumour DNA surveillance in patients with early high-risk hormone receptor positive, HER2-negative breast cancer in the TRAK-ER study. · 6/10 · Early Detection PMID 42937403 · ESR1 mutations and endocrine resistance in ER-positive breast cancer: Molecular mechanisms, liquid biopsy, and emerging targeted therapies. · 5/10 · Early Detection PMID 42938871 · Liquid Biopsy-Guided Surgical Decision-Making in Oligometastatic Non-Small Cell Lung Cancer: Toward Dynamic Risk Stratification in the Multidisciplinary Era. · 5/10 · Early Detection PMID 42938881 · Liquid Biopsy in Hepatobiliary and Pancreatic Malignancies: Current Evidence and Implications for Surgical Practice. · 5/10 · Early Detection PMID 42939051 · Breast Cancer Stem Cell-Associated Extracellular Vesicles: Bioengineering Advances in Source-Resolved Isolation, Mechanistic Validation, and Clinical Translation. · 5/10 · Early Detection
AI/ML in clinical diagnostics and imaging
PMID 42947327 · Predicting cardiovascular disease in peritoneal dialysis patients using glycated proteomics and machine learning: A prospective multicentre study. · 7/10 · Diagnostics PMID 42947589 · Predicting Polysomnography‑derived Sleep Efficiency and Total Sleep Time Using Clinical Questionnaires: A Machine Learning Approach. · 7/10 · Diagnostics PMID 42947532 · Development and Clinical Validation of a Stroke Risk Decision System for Patients With Carotid Artery Plaque Based on AI-Powered Handheld Ultrasound and Laboratory Markers. · 6/10 · Diagnostics PMID 42947537 · Early health technology assessment of machine learning-enabled remote monitoring for advanced Parkinson disease. · 5/10 · Diagnostics PMID 42946582 · HipSAFE: detecting hip fractures on ultrasound imaging using deep learning in a porcine cadaveric model. · 4/10 · Diagnostics
Precision oncology and genomic medicine
PMID 42937403 · ESR1 mutations and endocrine resistance in ER-positive breast cancer: Molecular mechanisms, liquid biopsy, and emerging targeted therapies. · 5/10 · Early Detection PMID 42946066 · TP53 Y220C Hotspot Mutation in Clinically Advanced Ovarian Carcinoma: Frequency and Genomic Features. · 5/10 · Genomics/Precision Medicine PMID 42947412 · Genome Sequencing Outperforms Exome Sequencing in Formalin-Fixed Paraffin Embedded Tumors Leading to Improved Treatment Options. · 5/10 · Genomics/Precision Medicine
Novel therapeutics: immunotherapy, CAR-T, targeted therapy
PMID 42937425 · An International Study of Pembrolizumab for Drug-Resistant Gestational Trophoblastic Neoplasia. · 5/10 · Treatment Innovation PMID 42946672 · Ovalbumin Functionalized Au-Pd Nanodumbbells Enable Photothermal-Immunotherapy With OVA-Associated Immune Activation. · 5/10 · Treatment Innovation
Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk
PMID 42946127 · Semaglutide and Panic Attacks: Active-Comparator Disproportionality Analysis, Temporal Assessment of Notoriety Bias and Evidence Triangulation in Post-Marketing Pharmacovigilance. · 5/10 · Public Health PMID 42946155 · Incretin and nutrient-sensing GPCR therapeutics in type 2 diabetes: what target-modality-formulation matching explains. · 5/10 · Public Health PMID 42946163 · SGLT2 Inhibitors and risk of bacteriuria, candiduria, and UTI-related hospitalization: A Nationwide Cohort Study. · 5/10 · Public Health PMID 42946946 · Interpreting Diabetic Retinal Outcomes After GLP-1 Receptor Agonist and Tirzepatide Initiation: Clinical Evidence and Its Limits. · 5/10 · Public Health PMID 42946972 · GLP-1-Based Therapy in Type 1 Diabetes: Balancing Efficacy, Safety, and Patient Selection. · 5/10 · Public Health
Aging, longevity, and population health
PMID 42937745 · Sleep duration, sarcopenia, and incident depressive symptoms in Chinese middle-aged and older adults: A prospective cohort study based on CHARLS. · 6/10 · Public Health PMID 42945057 · Evaluating the cost-effectiveness of enhanced cardiovascular-renal-metabolic (CVRM) screening in UK, France, Germany and Australia: a microsimulation-based enhanced CVRM screening analysis. · 6/10 · Public Health PMID 42946132 · The Estimated Health System Cost Impacts of Interventions to Reduce Alcohol Harm in New Zealand: A Modelling Study. · 6/10 · Public Health PMID 42944519 · Seat-Height Effects During Seated Shoe Donning in Older Adults: A Multi-Stage Ergonomic Evaluation Integrating Muscle Activity, Postural Exposure, and Subjective Comfort. · 5/10 · Public Health PMID 42945122 · Telemonitoring Adoption Among Older Adults: Sequential Mixed Methods Study of Message Framing and Structural Influence. · 5/10 · Public Health
Rare diseases with high unmet need
PMID 42944605 · Telomere biology disorders: recognizing the underrecognized through the lens of clinical genetics. · 6/10 · Treatment Innovation PMID 42946694 · Clinical Trajectories and Cardiac Phenotypes in Danon Disease. · 6/10 · Treatment Innovation PMID 42947409 · Arthroplasty After Hemophilia Gene Therapy: Perioperative Implications and Clinical Experience. · 6/10 · Treatment Innovation
💡 UNSOLICITED FINDS
PMID 42947434 · Efficacy and safety of Lianhua Qingwen versus oseltamivir in children with influenza: a multicenter, randomized, double-blind, positive parallel-controlled study. · 9/10 · Other PMID 42944679 · A clinical-radiological model for predicting in-hospital mortality in acute exacerbation of COPD. · 8/10 · Other PMID 42947498 · Effects of Walnut Consumption on Inflammatory Cytokines and Adipokines in Adults: A Systematic Review and Dose-Response Meta-Analysis. · 8/10 · Other PMID 42947526 · A Systematic Review and Meta-Analysis of Randomized Clinical Trials Comparing the Effectiveness of Corticosteroid Injection Versus Night Splints in Patients With Carpal Tunnel Syndrome. · 8/10 · Other
📊 TODAY'S BREAKDOWN
- By research category: Treatment Innovation 6 | Other 14 | Public Health 11 | Diagnostics 6 | Early Detection 6 | Genomics/Precision Medicine 2
- By evidence maturity: Exploratory 39 | Validated 6
- By watchlist topic:
- Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma): 15 reviewed / 5 kept / highest 5
- CBC-based diagnostics and machine learning in hematology: 5 reviewed / 1 kept / highest 5
- Early cancer detection (liquid biopsy, ctDNA, cfDNA): 15 reviewed / 6 kept / highest 6
- AI/ML in clinical diagnostics and imaging: 15 reviewed / 5 kept / highest 7
- Precision oncology and genomic medicine: 15 reviewed / 3 kept / highest 5
- Novel therapeutics: immunotherapy, CAR-T, targeted therapy: 15 reviewed / 2 kept / highest 5
- Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk: 15 reviewed / 6 kept / highest 8
- Aging, longevity, and population health: 15 reviewed / 5 kept / highest 6
- Rare diseases with high unmet need: 15 reviewed / 4 kept / highest 10
- Sentinel scan (unsolicited finds): 10 reviewed / 9 kept / highest 9
- By source type: peer_reviewed 45 | preprint 0
- Topics with zero HIGH articles this run: Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma); CBC-based diagnostics and machine learning in hematology; AI/ML in clinical diagnostics and imaging; Precision oncology and genomic medicine; Novel therapeutics: immunotherapy, CAR-T, targeted therapy; Aging, longevity, and population health
🔧 RUN NOTES
- Complete capped corpus regenerated for attempt 2; same-day records were not omitted.
- Per-topic cap: 15; T2 returned only 5 candidates. Sentinel cap: 10.
- 130 unique PMIDs were reconciled in both ESummary and EFetch; no endpoint coverage gaps remain.
- CRDT filtering is calendar-day based, so eligible early records on 2026-10-27 were retained.
- No 48-hour expansion was triggered.
- Duplicate Telegram alerts were suppressed; no alerts were sent by this attempt.